<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-28405" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Physiology, Residual Volume</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Lofrese</surname>
            <given-names>John J.</given-names>
          </name>
          <aff>Naval Medical Center San Diego</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Tupper</surname>
            <given-names>Connor</given-names>
          </name>
          <aff>Creighton University School of Medicine</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Denault</surname>
            <given-names>Deanna</given-names>
          </name>
          <aff>MGH Institute of Health Professions</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Lappin</surname>
            <given-names>Sarah L.</given-names>
          </name>
          <aff>Upstate University Hospital</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>John Lofrese declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Connor Tupper declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Deanna Denault declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sarah Lappin declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>27</day>
          <month>2</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-28405.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Residual volume (RV) is the volume of air&#x000a0;remaining&#x000a0;in the lungs after maximum forceful expiration. In other words, it is the volume of air that cannot be expelled from the lungs,&#x000a0;thus causing the&#x000a0;alveoli to remain&#x000a0;open&#x000a0;at all times.&#x000a0;The residual volume remains unchanged regardless of the lung volume at which expiration was started.<xref ref-type="bibr" rid="article-28405.r1">[1]</xref> Reference values for residual volume are 1 to 1.2 L, but these values are dependent on factors including age, gender, height, weight, and physical activity levels.<xref ref-type="bibr" rid="article-28405.r2">[2]</xref><xref ref-type="bibr" rid="article-28405.r3">[3]</xref>&#x000a0;See <bold>Image</bold>. Residual Volume.</p>
        <p>The residual volume is an important component of the total lung capacity (TLC) and the functional residual capacity (FRC). TLC is the total volume of the lungs at maximal inspiration which is about 6 L on average, though&#x000a0;true values are dependent on&#x000a0;the same factors that affect residual volume.<xref ref-type="bibr" rid="article-28405.r4">[4]</xref>&#x000a0;FRC is the amount of air remaining in the lungs after a normal, physiologic expiration (Figure 1A). The TLC, FRC, and RV are absolute lung volumes and cannot be measured directly with spirometry. Instead, they must be calculated using indirect measurement techniques such as gas dilution or body plethysmography.&#x000a0;Calculating the residual volume can give an indication of lung physiology and pathology.<xref ref-type="bibr" rid="article-28405.r5">[5]</xref></p>
      </sec>
      <sec id="article-28405.s2" sec-type="Function">
        <title>Function</title>
        <p>The residual volume functions to&#x000a0;maintain the patency of&#x000a0;alveoli even after maximal forced expiration. In healthy lungs, the air that makes up the residual volume&#x000a0;is utilized&#x000a0;for continual gas exchange between breaths.&#x000a0;Inspiration then draws atmospheric oxygen into the lungs to&#x000a0;replenish the oxygen-depleted residual air&#x000a0;for&#x000a0;gas exchange&#x000a0;in the alveoli.</p>
      </sec>
      <sec id="article-28405.s3" sec-type="Mechanism">
        <title>Mechanism</title>
        <p>Although breathing mechanics are complex, it is important to remember that air will flow from high-pressure&#x000a0;areas to low-pressure areas. During tidal breathing, the inspiration and expiration at physiologic rest, the volume of air entering and leaving the lungs is known as the tidal volume (TV). On tidal inspiration, inspiratory muscle contraction increases the volume of the chest causing the intrapleural pressure (Ppl)&#x000a0;to drop from -5 cm H2O to -8 cm H2O. The decreased Ppl causes the alveolar pressure (Palv) to decrease 1 cm H2O below atmospheric pressure. As a result, air from the relatively high-pressure atmosphere flows into the low-pressure alveoli.&#x000a0;Inspiration is an active process requiring the rhythmic contraction of inspiratory muscles that work to expand the chest cavity. Tidal expiration is a passive process that works in reverse. The inspiratory muscles relax, decreasing the size of the chest cavity, and increasing Ppl and Palv. Once Palv is greater than atmospheric pressure, air flows out of the lungs.&#x000a0;</p>
        <p>Residual volume can be understood by investigation of breathing&#x000a0;that exceeds&#x000a0;tidal volumes.&#x000a0;Following maximal inspiration, the volume of air that leaves the lungs&#x000a0;during a maximal force expiration is&#x000a0;known as the vital capacity (VC). VC is composed of the tidal volume, expiratory reserve volume (ERV), and inspiratory reserve volume (IRV). The ERV is the volume of air that can be forcefully exhaled after a normal resting expiration, leaving only the RV in the lungs. Forcefully exhaling the ERV is an active process requiring the contraction of expiratory muscles in the chest and abdomen. This increases Ppl and Palv above atmospheric pressure. Due to the elastic recoil of the alveoli, the pressure inside of the alveoli remains higher than that of the pleura, and the alveoli remain open. The pressure inside the airways (Paw) slowly decreases as you move up from the alveoli to the trachea as a result of increased airway resistance. In sections of small, non-cartilaginous airways, pleural pressure is greater than&#x000a0;airway pressure and causes a collapse of the airway (Figure 1B). The air that remains in the lungs after the collapse of all small airways is the residual volume.</p>
      </sec>
      <sec id="article-28405.s4" sec-type="Related Testing">
        <title>Related Testing</title>
        <p>There are no&#x000a0;methods to measure residual volume directly. Other lung volumes and capacities must first be measured directly before RV can be calculated. The first step in calculating RV is to determine the FRC. Measurement of the FRC can be done using one of the following three tests.</p>
        <p>
<bold>Helium Dilution Test</bold>
</p>
        <p>In this test, the patient inhales a known volume of air (V1) containing a known fraction of helium (FHe1) at end-expiration of tidal breathing, where the volume of air left in the lungs is equal to FRC. A spirometer measures the fraction of helium after equilibration in the lungs (FHe2).</p>
        <list list-type="bullet">
          <list-item>
            <p>FRC = V1(FHe1-FHe2) / FHe2</p>
          </list-item>
        </list>
        <p>
<bold>Nitrogen Washout</bold>
</p>
        <p>The nitrogen washout test utilizes the nitrogen that makes up 78% of atmospheric air. A patient breathes through a 2-way valve connected to 100% oxygen on inspiration and a collection spirometer on expiration. The spirometer measures the volume of air and fraction of nitrogen expired with each breath. Once the fraction of nitrogen is below 1.5% for 3 consecutive breaths, the test is complete. The initial amount of nitrogen in the lungs must be equal to the total amount of nitrogen exhaled, and thus the FRC can be calculated.</p>
        <list list-type="bullet">
          <list-item>
            <p>FRC = V&#x000a0;exhaled * C&#x000a0;exhaled N2 / C initial alveolar N2</p>
          </list-item>
        </list>
        <p>
<bold>Body Plethysmography</bold>
</p>
        <p>Plethysmography is based on Boyle&#x02019;s law of gases. In a closed system at a constant temperature, the product of pressure and volume of a known mass of gas is constant. That is to say, pressure and volume are inversely proportional.</p>
        <list list-type="bullet">
          <list-item>
            <p>P1V1 = P2V2</p>
          </list-item>
        </list>
        <p>To conduct the test, a patient is placed inside an enclosed chamber and breathes through a spirometer that can measure changes in pressure and volume. After a period of tidal breathing, the spirometer is closed at end-expiration, and the patient breathes against it. Changes in pressure at the mouthpiece are recorded. As the patient exhales, the volume of the thoracic cavity can be calculated by recording the change in pressure of the entire chamber. This test is the most accurate measure of FRC, but also the most expensive.</p>
        <p>Once the FRC has been measured using one of these three methods, the expiratory reserve volume (ERV) and vital capacity (VC) are measured using standard spirometry.&#x000a0;Calculations of TV and TLC can be made using the&#x000a0;measured FRC, ERV, and VC values and the following equations:</p>
        <list list-type="bullet">
          <list-item>
            <p>RV = FRC - ERV</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>TLC = VC + RV</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-28405.s5" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>
<bold>Obstructive Lung Disease (OLD)</bold>
</p>
        <p>Obstructive lung diseases, such as chronic obstructive pulmonary disease (COPD), asthma, and bronchiectasis, are characterized by airway inflammation, easily collapsible airways, expiratory flow obstruction, and air trapping that results in elevated RV relative to healthy lungs. In obstructive lung disease, factors such as inflammation, bronchoconstriction, excessive mucus, and decreased elastic recoil cause increased airway resistance and lead to earlier small airway closure during expiration. The premature airway closure increases the volume of air retained in the lungs at the end of expiration; this is referred to as air trapping. This trapped air results in pulmonary hyperinflation. Therefore patients with&#x000a0;obstructive lung disease have&#x000a0;elevated&#x000a0;TLC, FRC, and RV (Figure 1C).<xref ref-type="bibr" rid="article-28405.r6">[6]</xref><xref ref-type="bibr" rid="article-28405.r7">[7]</xref><xref ref-type="bibr" rid="article-28405.r8">[8]</xref>&#x000a0;These changes are reflected by the characteristic left shift associated with OLD seen on the flow-volume&#x000a0;loop during pulmonary function testing.&#x000a0;</p>
        <p>Body plethysmography yields a higher FRC in patients with obstructive lung disease than those measured by gas dilution techniques because it includes both well-ventilated and poorly ventilated areas of the lung. RV is generally the first volume to increase in&#x000a0;obstructive lung disease and can be a good measure to&#x000a0;evaluate early disease states. Additional findings on spirometry for OLD include decreased forced expiratory volume in the first second of expiration (FEV1), decreased forced vital capacity (FVC), and FEV1/FVC ratio &#x0003c;70% because FEV1 decreases more than FVC.&#x000a0;</p>
        <p>The RV/TLC ratio is used as a measure of resting pulmonary hyperinflation in patients with COPD. An elevated RC/TLC ratio&#x000a0;is a significant risk factor for all-cause mortality in COPD patients.<xref ref-type="bibr" rid="article-28405.r9">[9]</xref></p>
        <p>
<bold>Restrictive Lung Disease (RLD)</bold>
</p>
        <p>Restrictive lung diseases are a result of processes that restrict pulmonary expansion. The&#x000a0;restriction can be related to intrinsic diseases such as pulmonary fibrosis and sarcoidosis, or extrinsic processes like kyphosis and obesity. In either case, the result is restricted airway expansion that reduces the driving force for airflow into the lungs created by the negative pressure gradient which causes decreased lung volumes and inadequate ventilation.&#x000a0;TLC, FRC, and RV will all be decreased in restrictive lung disease. These changes are reflected by the characteristic right shift associated with RLD seen on the flow-volume loop during pulmonary function testing. Findings of spirometry include decreased FEV1 and FVC as seen in OLD, but the decrease in FEV1 and FVC is more uniform, or even more so in FVC, which results in a normal or elevated FEV1/FVC ratio.&#x000a0;</p>
        <p>The effects of obesity on lung function are a growing concern as the prevalence and severity of obesity increase. Studies have shown that increasing body mass index (BMI) correlates with lower VC, TLC, and RV, but these values remain within normal limits. Significant decreases in FRC and ERV are seen as BMI increases to the extent that FRC approaches RV.<xref ref-type="bibr" rid="article-28405.r10">[10]</xref><xref ref-type="bibr" rid="article-28405.r11">[11]</xref><xref ref-type="bibr" rid="article-28405.r12">[12]</xref>&#x000a0;<bold>&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0; </bold></p>
        <p>
<bold>Drowning</bold>
</p>
        <p>An interesting clinical use for residual volume is applied during post-mortem autopsies of drowning victims. The residual volume of air in the lungs can only be removed&#x000a0;if it is&#x000a0;replaced by another substance. In the case of drowning victims, water will replace the residual air in the lungs. During autopsies, medical examiners can clamp the trachea and submerge the lungs in water. If the lungs sink, no residual air remains,&#x000a0;so it is likely&#x000a0;the person drowned after inhaling large amounts of water. However, if the lungs float, the residual volume of air remains in the lungs. The residual volume was not replaced by water, so it is likely&#x000a0;the person died before entering the water.</p>
      </sec>
      <sec id="article-28405.s6">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=28405&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=28405">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/28405/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=28405">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-28405.s7">
        <fig id="article-28405.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Residual&#x000a0;Volume. Standard lung volumes and capacities (A), lung pressures at forceful expiration (B), and typical changes in lung volumes seen in restrictive and obstructive lung disease (C). Contributed by Lutfi, 2017; Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/)</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Screen__Shot__2018-03-07__at__12.39.21__PM" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-28405.s8">
        <title>References</title>
        <ref id="article-28405.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mortola</surname>
                <given-names>JP</given-names>
              </name>
            </person-group>
            <article-title>How to breathe? Respiratory mechanics and breathing pattern.</article-title>
            <source>Respir Physiol Neurobiol</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>261</volume>
            <fpage>48</fpage>
            <page-range>48-54</page-range>
            <pub-id pub-id-type="pmid">30605732</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28405.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kraemer</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Matthys</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Normative reference equations of airway dynamics assessed by whole-body plethysmography during spontaneous breathing evaluated in infants, children, and adults.</article-title>
            <source>Physiol Rep</source>
            <year>2021</year>
            <month>Sep</month>
            <volume>9</volume>
            <issue>17</issue>
            <fpage>e15027</fpage>
            <pub-id pub-id-type="pmid">34514738</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28405.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Haynes</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Kaminsky</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Stanojevic</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ruppel</surname>
                <given-names>GL</given-names>
              </name>
            </person-group>
            <article-title>Pulmonary Function Reference Equations: A Brief History to Explain All the Confusion.</article-title>
            <source>Respir Care</source>
            <year>2020</year>
            <month>Jul</month>
            <volume>65</volume>
            <issue>7</issue>
            <fpage>1030</fpage>
            <page-range>1030-1038</page-range>
            <pub-id pub-id-type="pmid">32156791</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28405.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Guillien</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Soumagne</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Regnard</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Degano</surname>
                <given-names>B</given-names>
              </name>
              <collab>Groupe Fonction de la SPLF</collab>
            </person-group>
            <article-title>[The new reference equations of the Global Lung function Initiative (GLI) for pulmonary function tests].</article-title>
            <source>Rev Mal Respir</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>35</volume>
            <issue>10</issue>
            <fpage>1020</fpage>
            <page-range>1020-1027</page-range>
            <pub-id pub-id-type="pmid">30448081</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28405.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Krol</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Morgan</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Khurana</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Pulmonary Function Testing and Cardiopulmonary Exercise Testing: An Overview.</article-title>
            <source>Med Clin North Am</source>
            <year>2019</year>
            <month>May</month>
            <volume>103</volume>
            <issue>3</issue>
            <fpage>565</fpage>
            <page-range>565-576</page-range>
            <pub-id pub-id-type="pmid">30955522</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28405.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Sol</surname>
                <given-names>IS</given-names>
              </name>
              <name>
                <surname>Sohn</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Yoon</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Shin</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>KW</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <article-title>Quantitative CT and pulmonary function in children with post-infectious bronchiolitis obliterans.</article-title>
            <source>PLoS One</source>
            <year>2019</year>
            <volume>14</volume>
            <issue>4</issue>
            <fpage>e0214647</fpage>
            <pub-id pub-id-type="pmid">30934017</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28405.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Clair</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mueller</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Livingstone-Banks</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Burnand</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Camain</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Cornuz</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>R&#x000e8;ge-Walther</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Selby</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Bize</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Biomedical risk assessment as an aid for smoking cessation.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2019</year>
            <month>Mar</month>
            <day>26</day>
            <volume>3</volume>
            <issue>3</issue>
            <fpage>CD004705</fpage>
            <pub-id pub-id-type="pmid">30912847</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28405.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gallucci</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Carbonara</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Pacilli</surname>
                <given-names>AMG</given-names>
              </name>
              <name>
                <surname>di Palmo</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ricci</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Nava</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Use of Symptoms Scores, Spirometry, and Other Pulmonary Function Testing for Asthma Monitoring.</article-title>
            <source>Front Pediatr</source>
            <year>2019</year>
            <volume>7</volume>
            <fpage>54</fpage>
            <pub-id pub-id-type="pmid">30891435</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28405.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shin</surname>
                <given-names>TR</given-names>
              </name>
              <name>
                <surname>Oh</surname>
                <given-names>YM</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Oh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kang</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Sheen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Seo</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Yoo</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>TH</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>Yoon</surname>
                <given-names>HI</given-names>
              </name>
              <name>
                <surname>Rhee</surname>
                <given-names>CK</given-names>
              </name>
              <name>
                <surname>Choe</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>SD</given-names>
              </name>
            </person-group>
            <article-title>The Prognostic Value of Residual Volume/Total Lung Capacity in Patients with Chronic Obstructive Pulmonary Disease.</article-title>
            <source>J Korean Med Sci</source>
            <year>2015</year>
            <month>Oct</month>
            <volume>30</volume>
            <issue>10</issue>
            <fpage>1459</fpage>
            <page-range>1459-65</page-range>
            <pub-id pub-id-type="pmid">26425043</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28405.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kishaba</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Acute Exacerbation of Idiopathic Pulmonary Fibrosis.</article-title>
            <source>Medicina (Kaunas)</source>
            <year>2019</year>
            <month>Mar</month>
            <day>16</day>
            <volume>55</volume>
            <issue>3</issue>
            <pub-id pub-id-type="pmid">30884853</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28405.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>de Carvalho</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Swash</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pinto</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Diaphragmatic Neurophysiology and Respiratory Markers in ALS.</article-title>
            <source>Front Neurol</source>
            <year>2019</year>
            <volume>10</volume>
            <fpage>143</fpage>
            <pub-id pub-id-type="pmid">30846968</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28405.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lumb</surname>
                <given-names>AB</given-names>
              </name>
            </person-group>
            <article-title>Pre-operative respiratory optimisation: an expert review.</article-title>
            <source>Anaesthesia</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>74 Suppl 1</volume>
            <fpage>43</fpage>
            <page-range>43-48</page-range>
            <pub-id pub-id-type="pmid">30604419</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
